PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
This protocol allows patients who completed Coley oncology studies using PF-3512676 (CPG
7909) Injection to continue receiving the treatment until disease progression.